相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression
Nina Schatz-Siemers et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor
Tiantian Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
Soyoung Choi et al.
MOLECULAR CANCER (2019)
A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis
Iacovos P. Michael et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells
Yao-Tseng Chen et al.
Oncotarget (2018)
HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development
Marisa Connell et al.
ELIFE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Elvira Pelosi et al.
BIOMEDICINES (2017)
Impaired Planar Germ Cell Division in the Testis, Caused by Dissociation of RHAMM from the Spindle, Results in Hypofertility and Seminoma
Huaibiao Li et al.
CANCER RESEARCH (2016)
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma
Dunrui Wang et al.
ONCOTARGET (2016)
RHAMM deficiency disrupts folliculogenesis resulting in female hypofertility
Huaibiao Li et al.
BIOLOGY OPEN (2015)
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer
David G. McFadden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Genetically Engineered Mouse Models of Pancreatic Cancer
Christoph Benedikt Westphalen et al.
CANCER JOURNAL (2012)
FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
Gideon M. Blumenthal et al.
ONCOLOGIST (2012)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis
Yi-Chieh Nancy Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Regulated Degradation of Spindle Assembly Factors by the Anaphase-Promoting Complex
Ling Song et al.
MOLECULAR CELL (2010)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
Sindy Sohr et al.
CELL CYCLE (2008)
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
Christopher Alan Maxwell et al.
JOURNAL OF CELL SCIENCE (2008)
Network modeling links breast cancer susceptibility and centrosome dysfunction
Miguel Angel Pujana et al.
NATURE GENETICS (2007)
The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly
Vladimir Joukov et al.
CELL (2006)
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
N Bardeesy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
A multitargeted, metronomic, and maximum-tolerated dose chemo-switch regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer
K Pietras et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive. bromatosis (desmoid tumor)
C Tolg et al.
ONCOGENE (2003)
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
G Bergers et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)